![A novel strategy for delivering Niemann‐Pick type C2 proteins across the blood–brain barrier using the brain endothelial‐specific AAV‐BR1 virus - Rasmussen - 2023 - Journal of Neurochemistry - Wiley Online Library A novel strategy for delivering Niemann‐Pick type C2 proteins across the blood–brain barrier using the brain endothelial‐specific AAV‐BR1 virus - Rasmussen - 2023 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e98e1941-43ed-4d43-be24-3d921e7b0058/jnc15621-fig-0008-m.png)
A novel strategy for delivering Niemann‐Pick type C2 proteins across the blood–brain barrier using the brain endothelial‐specific AAV‐BR1 virus - Rasmussen - 2023 - Journal of Neurochemistry - Wiley Online Library
![Sci. Pharm. | Free Full-Text | Overcoming the Blood–Brain Barrier. Challenges and Tricks for CNS Drug Delivery Sci. Pharm. | Free Full-Text | Overcoming the Blood–Brain Barrier. Challenges and Tricks for CNS Drug Delivery](https://www.mdpi.com/scipharm/scipharm-87-00006/article_deploy/html/images/scipharm-87-00006-g001.png)
Sci. Pharm. | Free Full-Text | Overcoming the Blood–Brain Barrier. Challenges and Tricks for CNS Drug Delivery
![Apolipoprotein E, low-density lipoprotein receptor, and immune cells control blood-brain barrier penetration by AAV-PHP.eB in mice Apolipoprotein E, low-density lipoprotein receptor, and immune cells control blood-brain barrier penetration by AAV-PHP.eB in mice](https://www.thno.org/v11/p1177/toc.jpg)
Apolipoprotein E, low-density lipoprotein receptor, and immune cells control blood-brain barrier penetration by AAV-PHP.eB in mice
Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids | PLOS ONE
![AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice | ASGCT - American Society of Gene & Cell Therapy AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice | ASGCT - American Society of Gene & Cell Therapy](https://asgct.org/ASGCT/media/about/September-Vector-blog-visual-(1).png)
AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice | ASGCT - American Society of Gene & Cell Therapy
![Frontiers | A Multifaceted Approach to Optimizing AAV Delivery to the Brain for the Treatment of Neurodegenerative Diseases Frontiers | A Multifaceted Approach to Optimizing AAV Delivery to the Brain for the Treatment of Neurodegenerative Diseases](https://www.frontiersin.org/files/Articles/747726/fnins-15-747726-HTML/image_m/fnins-15-747726-g001.jpg)
Frontiers | A Multifaceted Approach to Optimizing AAV Delivery to the Brain for the Treatment of Neurodegenerative Diseases
Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids | PLOS ONE
![Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection - ScienceDirect Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0024320521001272-gr1.jpg)
Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection - ScienceDirect
![Variants of the adeno-associated virus serotype 9 with enhanced penetration of the blood–brain barrier in rodents and primates | Nature Biomedical Engineering Variants of the adeno-associated virus serotype 9 with enhanced penetration of the blood–brain barrier in rodents and primates | Nature Biomedical Engineering](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41551-022-00938-7/MediaObjects/41551_2022_938_Fig1_HTML.png)
Variants of the adeno-associated virus serotype 9 with enhanced penetration of the blood–brain barrier in rodents and primates | Nature Biomedical Engineering
![The human brain endothelial barrier: transcytosis of AAV9, transduction by AAV2 - Weber‐Adrian - 2017 - Journal of Neurochemistry - Wiley Online Library The human brain endothelial barrier: transcytosis of AAV9, transduction by AAV2 - Weber‐Adrian - 2017 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/96c87a82-1470-4e9f-b2b5-2fb235c52c14/jnc13898-toc-0001-m.jpg?trick=1669595814123)
The human brain endothelial barrier: transcytosis of AAV9, transduction by AAV2 - Weber‐Adrian - 2017 - Journal of Neurochemistry - Wiley Online Library
![An adeno-associated virus vector penetrates the blood–brain barrier in non-human primates | Nature Biomedical Engineering An adeno-associated virus vector penetrates the blood–brain barrier in non-human primates | Nature Biomedical Engineering](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41551-022-00939-6/MediaObjects/41551_2022_939_Fig1_HTML.png)
An adeno-associated virus vector penetrates the blood–brain barrier in non-human primates | Nature Biomedical Engineering
![A brain microvasculature endothelial cell‐specific viral vector with the potential to treat neurovascular and neurological diseases | EMBO Molecular Medicine A brain microvasculature endothelial cell‐specific viral vector with the potential to treat neurovascular and neurological diseases | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/1f1c5404-60be-490f-876d-dba9ec3d9f9f/emmm201506078-fig-0008-m.jpg)
A brain microvasculature endothelial cell‐specific viral vector with the potential to treat neurovascular and neurological diseases | EMBO Molecular Medicine
![Endothelium-Macrophage Crosstalk Mediates Blood-Brain Barrier Dysfunction in Hypertension | Hypertension Endothelium-Macrophage Crosstalk Mediates Blood-Brain Barrier Dysfunction in Hypertension | Hypertension](https://www.ahajournals.org/cms/asset/bd5fb311-a5f0-45bd-894c-b2f272862e99/hypertensionaha.120.15581.fig07.jpg)
Endothelium-Macrophage Crosstalk Mediates Blood-Brain Barrier Dysfunction in Hypertension | Hypertension
![Selection of rAAV vectors that cross the human blood-brain barrier and target the central nervous system using a transwell model: Molecular Therapy - Methods & Clinical Development Selection of rAAV vectors that cross the human blood-brain barrier and target the central nervous system using a transwell model: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/1858976c-e02d-4b58-9a5f-c65ac8f9915b/fx1_lrg.jpg)
Selection of rAAV vectors that cross the human blood-brain barrier and target the central nervous system using a transwell model: Molecular Therapy - Methods & Clinical Development
![AAV9-Retro mediates efficient transduction with axon terminal absorption and blood–brain barrier transportation | Molecular Brain | Full Text AAV9-Retro mediates efficient transduction with axon terminal absorption and blood–brain barrier transportation | Molecular Brain | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13041-020-00679-1/MediaObjects/13041_2020_679_Fig1_HTML.png)
AAV9-Retro mediates efficient transduction with axon terminal absorption and blood–brain barrier transportation | Molecular Brain | Full Text
![Frontiers | A Multifaceted Approach to Optimizing AAV Delivery to the Brain for the Treatment of Neurodegenerative Diseases Frontiers | A Multifaceted Approach to Optimizing AAV Delivery to the Brain for the Treatment of Neurodegenerative Diseases](https://www.frontiersin.org/files/MyHome%20Article%20Library/747726/747726_Thumb_400.jpg)